Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Phathom Pharmaceuticals, Inc.

Clinical trials sponsored by Phathom Pharmaceuticals, Inc., explained in plain language.

Phathom Pharmaceuticals, Inc. PHAT NASDAQ

A biopharmaceutical company developing gastrointestinal treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a new pill stop heartburn in its tracks?

Symptom relief Not yet recruiting

This trial tests whether vonoprazan, taken as needed, can quickly relieve heartburn episodes in adults with non-erosive gastroesophageal reflux disease (GERD). Participants will take either vonoprazan or a placebo when they experience heartburn, and researchers will track how wel…

Phase: PHASE3 • Sponsor: Phathom Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Aug 09, 2026 00:00 UTC